Atorvastatin Calcium Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

What was recalled

Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20

Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
NDC code: 51079-208-20
Origin: IL, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-0622-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Atorvastatin recalls

See all

Class II · Moderate risk Ongoing Sep 19, 2025